IL6 and myeloid sarcoma: For example, and collectively, much of the work incorporated small and unequal sample sizes together with asymmetrically distributed data that would alter statistical power, as acknowledged by Wullschleger et al [155], who measured IL-6 concentrations in CSF taken from patients with MS and other neurological inflammatory diseases.